Skip to Main Content

Paper Details

Tyrosine Kinase Inhibitors Increase MCL1 Degradation and in Combination with BCLXL/BCL2 Inhibitors Drive Prostate Cancer Apoptosis.
Clin Cancer Res
42
2018
Author NameAffiliation
Eva CoreyUniversity of Washington School of Medicine
Steven P Balkand Cancer Center, Beth Israel Deaconess Medical Center and Harvard Medical School
  • 1 - 2

Datasets

Release 1.2